Stock listing
Stuttgart:8C5 Coherus Oncology, Inc. Aktie
German listing (Stuttgart) of Coherus Oncology, Inc. · home listing NASDAQ:CHRS
Follow Coherus Oncology, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:CHRS
$0.749 USD -0.081 (-9.7%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:CHRS
- Day range
- $0.746 – $0.838 USDNov 2, 2026
- Volume
- 2.61M sharesNov 2, 2026
- Market cap
- $115.8M USDAt the close on Nov 2, 2026 · price × 154.5M shares outstanding
- 52-week range
- $0.746 – $2.616 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $1.69M USDMedian day 1.18M shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CHRS · Home | $0.749 USD | -0.081 (-9.7%) | 2,608,622 | $0.835 | $0.838 | $0.746 | $0.830 | Close on Nov 2, 2026 |
| Frankfurt:8C5 | €0.784 EUR | -0.106 (-12.0%) | — | €0.784 | €0.784 | €0.784 | €0.891 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:CHRS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.749 | -0.081 | -9.7% | $0.835 | $0.838 | $0.746 | 2,608,622 | |
| $0.830 | -0.068 | -7.6% | $0.900 | $0.918 | $0.824 | 2,186,100 | |
| $0.898 | -0.262 | -22.6% | $1.150 | $1.150 | $0.805 | 6,132,000 | |
| $1.160 | +0.090 | +8.4% | $1.080 | $1.170 | $1.050 | 1,400,200 | |
| $1.070 | +0.060 | +5.9% | $1.030 | $1.070 | $1.010 | 604,100 | |
| $1.010 | 0.000 | 0.0% | $1.010 | $1.020 | $0.980 | 686,800 | |
| $1.010 | -0.040 | -3.8% | $1.030 | $1.038 | $0.988 | 641,400 | |
| $1.050 | +0.030 | +2.9% | $1.020 | $1.060 | $1.015 | 641,900 | |
| $1.020 | +0.020 | +2.0% | $1.010 | $1.050 | $1.005 | 1,272,500 | |
| $1.000 | +0.041 | +4.3% | $0.960 | $1.030 | $0.955 | 967,700 | |
| $0.959 | -0.031 | -3.1% | $1.000 | $1.015 | $0.940 | 1,726,200 | |
| $0.990 | -0.080 | -7.5% | $1.070 | $1.070 | $0.987 | 938,500 | |
| $1.070 | +0.020 | +1.9% | $1.070 | $1.090 | $1.030 | 1,541,600 | |
| $1.050 | -0.020 | -1.9% | $1.050 | $1.085 | $1.011 | 1,716,300 | |
| $1.070 | +0.040 | +3.9% | $1.060 | $1.080 | $1.000 | 1,342,100 | |
| $1.030 | -0.040 | -3.7% | $1.060 | $1.066 | $1.030 | 1,036,300 | |
| $1.070 | 0.000 | 0.0% | $1.060 | $1.120 | $1.050 | 1,697,100 | |
| $1.070 | +0.060 | +5.9% | $1.010 | $1.070 | $0.974 | 2,135,100 | |
| $1.010 | -0.020 | -1.9% | $1.020 | $1.080 | $1.010 | 1,233,300 | |
| $1.030 | -0.090 | -8.0% | $1.130 | $1.130 | $1.010 | 2,965,300 | |
| $1.120 | -0.040 | -3.4% | $1.160 | $1.160 | $1.080 | 2,008,500 | |
| $1.160 | 0.000 | 0.0% | $1.190 | $1.190 | $1.145 | 1,183,200 | |
| $1.160 | -0.050 | -4.1% | $1.200 | $1.210 | $1.145 | 709,200 | |
| $1.210 | +0.030 | +2.5% | $1.180 | $1.230 | $1.155 | 1,579,800 | |
| $1.180 | +0.040 | +3.5% | $1.150 | $1.200 | $1.120 | 1,346,800 | |
| $1.140 | +0.010 | +0.9% | $1.130 | $1.150 | $1.100 | 1,143,300 | |
| $1.130 | -0.040 | -3.4% | $1.170 | $1.185 | $1.130 | 1,221,400 | |
| $1.170 | -0.090 | -7.1% | $1.250 | $1.265 | $1.170 | 1,561,600 | |
| $1.260 | -0.040 | -3.1% | $1.300 | $1.310 | $1.210 | 1,615,700 | |
| $1.300 | -0.070 | -5.1% | $1.390 | $1.390 | $1.220 | 4,535,100 | |
| $1.370 | +0.020 | +1.5% | $1.350 | $1.430 | $1.300 | 1,489,500 | |
| $1.350 | +0.120 | +9.8% | $1.230 | $1.350 | $1.225 | 3,121,100 | |
| $1.230 | +0.010 | +0.8% | $1.260 | $1.270 | $1.180 | 1,885,500 | |
| $1.220 | -0.110 | -8.3% | $1.340 | $1.350 | $1.210 | 1,289,600 | |
| $1.330 | -0.100 | -7.0% | $1.380 | $1.390 | $1.320 | 762,000 | |
| $1.430 | +0.100 | +7.5% | $1.340 | $1.430 | $1.340 | 1,274,900 | |
| $1.330 | -0.010 | -0.7% | $1.378 | $1.380 | $1.325 | 529,200 | |
| $1.340 | +0.020 | +1.5% | $1.330 | $1.360 | $1.300 | 1,019,100 | |
| $1.320 | -0.050 | -3.6% | $1.340 | $1.375 | $1.310 | 840,600 | |
| $1.370 | -0.050 | -3.5% | $1.400 | $1.430 | $1.360 | 549,200 | |
| $1.420 | +0.050 | +3.6% | $1.380 | $1.435 | $1.380 | 304,100 | |
| $1.370 | -0.050 | -3.5% | $1.420 | $1.430 | $1.360 | 437,200 | |
| $1.420 | +0.050 | +3.6% | $1.370 | $1.435 | $1.355 | 621,400 | |
| $1.370 | +0.020 | +1.5% | $1.360 | $1.400 | $1.350 | 695,100 | |
| $1.350 | -0.060 | -4.3% | $1.390 | $1.410 | $1.300 | 1,127,700 | |
| $1.410 | -0.050 | -3.4% | $1.450 | $1.480 | $1.400 | 604,800 | |
| $1.460 | +0.010 | +0.7% | $1.430 | $1.480 | $1.410 | 788,300 | |
| $1.450 | +0.080 | +5.8% | $1.370 | $1.455 | $1.340 | 896,500 | |
| $1.370 | +0.010 | +0.7% | $1.360 | $1.410 | $1.310 | 1,297,214 | |
| $1.360 | -0.060 | -4.2% | $1.430 | $1.430 | $1.350 | 1,046,359 | |
| $1.420 | +0.100 | +7.6% | $1.320 | $1.440 | $1.315 | 1,565,300 | |
| $1.320 | -0.010 | -0.8% | $1.310 | $1.340 | $1.270 | 740,200 | |
| $1.330 | -0.010 | -0.7% | $1.379 | $1.405 | $1.295 | 3,038,100 | |
| $1.340 | +0.190 | +16.5% | $1.260 | $1.360 | $1.220 | 3,477,700 | |
| $1.150 | -0.050 | -4.2% | $1.200 | $1.200 | $1.130 | 1,264,600 | |
| $1.200 | +0.060 | +5.3% | $1.160 | $1.205 | $1.140 | 648,300 | |
| $1.140 | -0.030 | -2.6% | $1.180 | $1.195 | $1.130 | 1,060,000 | |
| $1.170 | -0.040 | -3.3% | $1.210 | $1.246 | $1.170 | 1,155,500 | |
| $1.210 | -0.030 | -2.4% | $1.250 | $1.260 | $1.180 | 968,300 | |
| $1.240 | -0.030 | -2.4% | $1.330 | $1.340 | $1.230 | 978,100 | |
| $1.270 | +0.005 | +0.4% | $1.270 | $1.400 | $1.240 | 1,600,200 | |
| $1.265 | -0.185 | -12.8% | $1.385 | $1.455 | $1.131 | 3,721,800 | |
| $1.450 | -0.030 | -2.0% | $1.480 | $1.525 | $1.435 | 999,300 | |
| $1.480 | +0.040 | +2.8% | $1.430 | $1.500 | $1.430 | 617,700 | |
| $1.440 | +0.030 | +2.1% | $1.420 | $1.459 | $1.414 | 477,300 |
- Ticker
- Stuttgart:8C5
- Asset type
- Stock
- Exchange
- Stuttgart
- Currency
- EUR
What changed lately
Latest news release · Oct 28, 2026
Coherus Oncology Announces Compelling Tagmokitug Interim Clinical Data in Esophageal Cancer and Path to Advance Development
Latest earnings call · Aug 5, 2026
Coherus Oncology (NASDAQ:CHRS) Q2 2026 Earnings Call
Replay and transcript
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 25 slides
Calls
Upcoming
Coherus Oncology (NASDAQ:CHRS) Q3 2026 Earnings Call
Mon, Nov 09, 2026 · 5:00 PM ET
Register
Replays
Coherus Oncology (NASDAQ:CHRS) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 5:00 PM ET
Watch TranscriptCoherus Oncology (NASDAQ:CHRS) Q1 2026 Earnings Call
Mon, May 11, 2026 · 5:00 PM ET
Watch TranscriptCoherus Oncology (NASDAQ:CHRS) Q4 2025 Earnings Call
Mon, Mar 09, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Coherus Oncology Announces Compelling Tagmokitug Interim Clinical Data in Esophageal Cancer and Path to Advance Development
Oct 28, 2026
Closed $0.898 (-22.6%) on Oct 29, 2026
Coherus to Participate in Upcoming Investor Conferences
Oct 27, 2026
Closed $1.07 (+5.9%) on Oct 27, 2026
Coherus Oncology to Report Third Quarter 2026 Financial Results on November 9, 2026
Oct 26, 2026
Closed $1.01 (0.0%) on Oct 26, 2026
Coherus Oncology to Host Webcast to Disclose Interim Tagmokitug Clinical Data on October 28, 2026
Oct 14, 2026
Closed $1.07 (+1.9%) on Oct 15, 2026
Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets
Sep 23, 2026
Closed $1.26 (-3.1%) on Sep 23, 2026
Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights
Aug 17, 2026
Closed $1.34 (+16.5%) on Aug 18, 2026
Coherus Oncology Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 5, 2026
Closed $1.27 (-12.8%) on Aug 6, 2026
Coherus Oncology to Report Second Quarter 2026 Financial Results on August 5, 2026
Jul 22, 2026
Closed $1.43 (-2.7%) on Jul 22, 2026
Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi)
Jun 23, 2026
Closed $1.46 (-1.4%) on Jun 23, 2026
Coherus Oncology Reports First Quarter 2026 Financial Results and Provides Business Update
May 11, 2026
Closed $1.95 (+11.4%) on May 11, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 25 slides · September 2026
Q4 2025 Earnings Presentation
Earnings · 30 slides · Mar 9, 2026
Coherus BioSciences — 43rd Annual J.P. Morgan Healthcare Conference January 2025
Conference · 42 slides · Jan 14, 2025
Coherus BioSciences — Bank of America Merrill Lynch Health Care Conference 2016
Conference · 31 slides · May 11, 2016
Coherus Oncology, Inc. on 6ix
- News releases
- 24 in the last 12 months · 160 in all · newest Oct 28, 2026 · oldest 2019
- Calls
- 23 calls with a replay · 23 with a transcript · latest Aug 5, 2026
- Decks
- 4 decks · latest September 2026
Where Coherus Oncology, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CHRS · Home listing | NASDAQ | United States | USD |
| Tradegate:8C5 | Tradegate | Germany | EUR |
| gettex:8C5 | gettex | Germany | EUR |
| Lang & Schwarz:A12ETZ | Lang & Schwarz | Germany | EUR |
| LS Exchange:A12ETZ | LS Exchange | Germany | EUR |
| BOATS:CHRS | BOATS | United States | USD |
| BX Swiss:8C5 | BX Swiss | Switzerland | CHF |
| Dusseldorf:8C5 | Dusseldorf | Germany | EUR |
| Frankfurt:8C5 | Frankfurt | Germany | EUR |
| Munich:8C5 | Munich | Germany | EUR |
| Stuttgart:8C5 · This page | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Coherus Oncology, Inc.